YOLFTbeta
10

InBioGen Co Ltd

101140 · KO · Consumer Cyclical / Footwear & Accessories

4,820.00KRW+25.00 (+0.52%)

Price History

Full chart

Market Stats

Previous Close4,795.00
Open4,730.00
Day Range4,710.00 – 5,000.00
52-Week Range4,255.00 – 14,300.00
Volume903
Market Cap46.73B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.83
50-Day Avg5,184.60
200-Day Avg7,990.15

About

INBIOGEN Co., Ltd. engages in the manufacture and distribution of footwear products in South Korea. It is also involved in distribution of wood pellets; kiosk; and food and beverage businesses. The company was formerly known as BTONE CO.,Ltd. INBIOGEN Co., Ltd. was founded in 1949 and is headquartered in Seoul, South Korea.

Company Details

  • SectorConsumer Cyclical
  • IndustryFootwear & Accessories
  • CEOMr. Moo-Hyung Choi
  • Employees0
  • HeadquartersInitial Tower ', Seoul, South Korea, Korea
  • Websitehttps://www.inbiogen.co.kr

Leadership

  • Mr. Moo-Hyung ChoiChief Executive Officer · b. 1958

Financials

Income Statement

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue7.97B11.76B8.86B11.55B7.08B7.57B9.80B10.22B10.48B11.40B6.24B7.04B6.30B
Growth (%)-+47.65%-24.63%+30.23%-38.70%+6.92%+29.46%+4.31%+2.58%+8.81%-45.27%+12.82%-10.57%
Cost of Revenue6.50B10.14B9.28B9.92B6.58B6.76B8.72B9.41B8.52B8.84B4.91B6.38B6.64B
Gross Profit1.47B1.63B-418.18M1.63B494.87M807.54M1.07B812.06M1.96B2.56B1.33B660.07M-347.32M
Gross Margin18.41%13.83%-4.72%14.11%6.99%10.67%10.94%7.95%18.69%22.47%21.33%9.37%-5.52%
Operating Expense2.72B2.90B4.62B3.76B2.03B-559.64M3.20B6.22B9.64B8.50B7.47B6.75B3.99B
Operating Income-1.26B-1.27B-5.04B-2.13B-1.53B1.37B-2.13B-5.41B-7.69B-5.93B-6.14B-6.09B-4.33B
Operating Margin-15.78%-10.81%-56.84%-18.47%-21.64%18.07%-21.71%-52.95%-73.33%-52.03%-98.38%-86.45%-68.81%
EBITDA-----1.10B1.40B17.64B-38.54B116.01B-131.51B13.34B17.23B-976.72M
EBITDA Margin-----15.61%18.53%180.10%-377.21%1106.89%-1153.23%213.83%244.72%-15.51%
Net Income-1.38B-1.61B-5.69B-2.26B-1.21B1.66B13.12B-45.08B94.12B-119.69B11.34B16.12B-1.42B
Net Income Margin-17.33%-13.71%-64.14%-19.54%-17.11%21.99%133.98%-441.17%898.07%-1049.54%181.77%228.98%-22.53%
R&D8.75M20.54M------24.60M3.67M8.19M21.89M-
R&D as % of Total Revenue0.11%0.17%------0.23%0.03%0.13%0.31%-
Interest Expense0000004.26B6.23B3.83B3.69B262.14M51.35M78.45M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%43.52%61.00%36.54%32.36%4.20%0.73%1.25%

Balance Sheet

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets10.00B7.11B14.56B12.38B13.39B24.32B90.92B96.88B274.47B141.81B151.31B162.73B159.99B
Total Liabilities6.33B2.99B6.76B6.62B2.07B968.80M24.92B18.97B96.45B37.40B2.62B2.89B2.35B
Total Equity3.67B4.12B7.80B5.75B11.32B23.35B66.00B77.91B178.02B104.42B148.68B159.84B157.64B
Cash1.02B352.78M185.78M435.29M251.27M617.29M8.04B9.11B23.15B9.29B6.09B5.72B901.70M
Net Debt----106.61M-1.48B------

Cash Flow

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.13B-695.95M-10.96B344.75M-426.44M-1.70B-3.83B-8.03B-7.07B-11.51B-1.05B-33.13M-5.55B
Investing Cash Flow-605.35M517.48M-133.69M8.98M-4.31B-15.89B-55.04B-5.87B-40.44B-15.92B---
Financing Cash Flow2.57B-489.56M10.92B-104.22M4.55B17.97B66.29B14.97B61.54B13.57B---
Capital Expenditure98.53M24.25M138.24M0288.35M288.35M288.35M427.91M2.36B130.68M330.96M84.28M42.50M
Free Cash Flow-----426.44M-1.70B-4.24B-9.00B-9.47B-11.84B-1.38B-117.41M-5.60B
FCF to OCF----100.00%100.00%110.87%112.09%133.97%102.87%131.50%354.38%100.77%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 16, 2016Nov 14, 2016Feb 20, 2017May 15, 2017Aug 11, 2017Nov 13, 2017Feb 19, 2018May 11, 2018Aug 13, 2018Nov 14, 2018Dec 31, 2018May 15, 2019Aug 14, 2019Nov 14, 2019Feb 14, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022
EPS Estimate--------------------------------------------------------
EPS Actual-80.12-152.84-203.31632.92-62.97-1057.9763.18-657.53-61.3215.92-4.32115.48-15.28-34.34-18.35-54.17-21.21-7.65-26.95-67.18-27.14-61.44-22.81-29.766.69-28.65-14.39-246.20-16.98-25.07-23.99-46.61-6.06-18.42-3.77-26.50-1.81-3.21120.43-42.00-6.119.486.08-219.01-27.92-159.50-134.84-765.31743.23-981.82-299.712246.09-739.92-885.97-96.13106.51
Surprise--------------------------------------------------------
Timing-----------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours------------

Key Statistics & Ratios

Market Cap46.73B
Enterprise Value50.64B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales9.16
Price / Book0.35
Revenue (TTM)5.10B
Gross Profit (TTM)-566.80M
EBITDA-3.78B
Profit Margin0.00%
Operating Margin-61.23%
Return on Equity-13.63%
Return on Assets-1.57%
Shares Outstanding9.98M
Shares Float2.06M
Beta0.83
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 21, 20230.05:1
  • Sep 17, 200810:1